Core Viewpoint - The company Xinhecheng (002001.SZ) has reported significant growth in its financial performance for 2024, with a revenue of 21.61 billion yuan, marking a year-on-year increase of 42.95%, and a net profit of 5.87 billion yuan, reflecting a substantial growth of 117.01% [1][3]. Financial Performance - In 2024, Xinhecheng achieved a record high in both revenue and net profit, with total revenue reaching 21.61 billion yuan and net profit at 5.87 billion yuan [1][3]. - The company expects to continue this growth trend into Q1 2025, projecting a net profit of 1.8 billion to 1.9 billion yuan, which represents a year-on-year increase of 107% to 118% [2][4]. Product Performance - The nutrition product segment, which is the company's main revenue driver, generated 15.06 billion yuan, accounting for 69.67% of total revenue, and experienced a year-on-year growth of 52.58% [4]. - The company has seen a recovery in market prices for its main products due to the revival of the downstream aquaculture industry and supply constraints from other manufacturers [3][4]. Shareholder Returns - Xinhecheng announced a total dividend distribution of 2.151 billion yuan for 2024, which is 36.6% of the company's net profit for the year [5]. - The company will initiate its second share buyback in history, with a planned amount between 300 million to 600 million yuan, aimed at employee stock ownership plans [2][6]. Historical Context - Since its listing in 2004, Xinhecheng has distributed a total of 15.5 billion yuan in dividends, with a cumulative dividend payout ratio of 42.93% [6].
新和成年度净利58.69亿同比翻倍 推第二次股份回购最高将斥资6亿